Association of high-dose radiotherapy with improved survival in patients with newly diagnosed low-grade gliomas.
Yanwei LiuShuai LiuGuanzhang LiYanong LiLi ChenJin FengYong YangTao JiangXiaoguang QiuPublished in: Cancer (2021)
The radiotherapy dose-response was observed in patients with low-grade gliomas, and high-dose radiotherapy (≥54 Gy) was associated with improved survival. Patients with an IDH mutation/1p/19q noncodeletion or wild-type IDH may have improved survival with the administration of high-dose radiotherapy.